Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SmithKline Beecham's Tagamet

This article was originally published in The Tan Sheet

Executive Summary

"There is a chance" that the Rx-to-OTC switch application could be approved based on available date, SmithKline Beecham CEO Robert Bauman told the Bear Sterns Health Care Conference Sept. 20 in New York City. Bauman noted that during the advisory committee review of the cimetidine switch application, "we did not have sufficient numbers to prove effectiveness in one day usage" ("The Tan Sheet" Sept. 13, p. 1). The company is "working with [FDA] to see if we can find additional data and additional ways to look at it . . . to see if we can demonstrate that effectiveness. I think there is a belief by them and everyone that Tagamet is going to be effective," he maintained. "If we must go back and do additional trials in order to support the effectiveness . . . then it will obviously take longer for approval".
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS081964

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel